Indi Molecular

Indi Molecular

Biotechnology, 525 Morris St, Culver City, California, 70538, United States, 1-10 Employees

indimolecular.com

  • LinkedIn

phone no Phone Number: 31********

Who is INDI MOLECULAR

Indi Molecular is developing protein catalyzed capture (PCC) agents as a small synthetic molecule replacement for antibody-based therapeutics. PCCs are poised to play a central role in th...

Read More

map
  • 525 Morris St, Culver City, California, 70538, United States Headquarters: 525 Morris St, Culver City, California, 70538, United States
  • 2013 Date Founded: 2013
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8211

checked-icon Does something look wrong? Fix it. | View contact records from INDI MOLECULAR

Indi Molecular Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Indi Molecular

Answer: Indi Molecular's headquarters are located at 525 Morris St, Culver City, California, 70538, United States

Answer: Indi Molecular's phone number is 31********

Answer: Indi Molecular's official website is https://indimolecular.com

Answer: Indi Molecular's revenue is $25 Million to $50 Million

Answer: Indi Molecular's SIC: 8211

Answer: Indi Molecular has 1-10 employees

Answer: Indi Molecular is in Biotechnology

Answer: Indi Molecular contact info: Phone number: 31******** Website: https://indimolecular.com

Answer: Indi Molecular is developing protein catalyzed capture (PCC) agents as a small synthetic molecule replacement for antibody-based therapeutics. PCCs are poised to play a central role in therapy given their ability to be deployed as both a precision in vivo PET diagnostic and as a targeted therapeutic. For radiotherapy this dual role is accomplished by choice of the complexed radionuclide sharing the same chelation chemistry. Chemotherapy can similarly be specifically delivered to diseased cells by the protein catalyzed capture technology. The company launched in 2013 with a $1.8 million seed round, followed by an $11.5 million Series A in 2017.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access